BNP Paribas Easy (BLUE) | Stock Overview & Key Data

BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF | Mid-cap | Healthcare

€15.53

-1.82%

BNP Paribas Easy vs Abivax SA BNP Paribas Easy vs Medincell S.A BNP Paribas Easy vs Valneva SE BNP Paribas Easy vs Inventiva S.A BNP Paribas Easy vs Nanobiotix BNP Paribas Easy vs CAC 40 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

BNP Paribas Easy Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	BNP Paribas Easy	Healthcare Sector	CAC 40
1 Week	-2.20%	N/A	N/A
1 Month	-0.89%	N/A	N/A
3 Months	0.52%	N/A	N/A
6 Months	-5.19%	N/A	N/A
1 Year	-2.63%	N/A	N/A
3 Years	1.50%	N/A	N/A
5 Years	49.76%	N/A	N/A

Stock Range

Today's Range

Low: €15.53 High: €15.60

on August 1, 2025

52 Week Range

Low: €13.83 High: €16.93

on April 7, 2025

on October 17, 2024

All-Time High: €40.48 on June 30, 2014

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €463.1M

EPS i N/A

P/E Ratio (TTM) i 15.99

Forward P/E i N/A

P/B Ratio i N/A

PEG Ratio i N/A

Div. Yield i N/A

ROE i -96.39%

Beta i N/A

Debt to Equity i 2.22

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i -156.86%

Profit Margin i -27.22%

Returns and Earnings

Return on Assets (TTM) i -23.08%

Return on Equity (TTM) i -96.39%

EBITDA i €0

Net Income (TTM) i €-42.9M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i €0.90

Quarterly Revenue Growth (YoY) i N/A

Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
BNP Paribas Easy BLUE	463.10M Mid-cap	-2.20%	-0.89%	0.52%	-5.19%	-5.19%	-2.63%	1.50%	49.76%
Abivax SA ABVX	4.49B Large-cap	-5.31%	791.18%	913.38%	961.30%	732.42%	474.95%	572.59%	214.97%
Medincell S.A MEDCL	524.62M Mid-cap	-6.41%	-1.79%	2.65%	0.70%	-9.29%	-0.06%	197.92%	112.23%
Valneva SE VLA	546.93M Mid-cap	9.79%	50.21%	22.53%	14.70%	55.41%	11.58%	-65.68%	-34.65%
Inventiva S.A IVA	391.52M Mid-cap	0.70%	8.71%	-10.87%	23.18%	36.02%	32.41%	-46.04%	-71.29%
Nanobiotix NANO	283.01M Mid-cap	-1.63%	44.95%	97.06%	55.81%	96.42%	35.01%	44.96%	-15.35%

Ownership & Short Interest

Insider Ownership i N/A

Institutional Ownership i N/A

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 438

Average 90-Day Volume i 3K

BNP Paribas Easy Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in BNP Paribas Easy would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of BNP Paribas Easy, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -2.20%
1 Month: -0.89%
3 Months: 0.52%
1 Year: -2.63%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BLUE's 52-week high and low?

In the last 52 weeks, BNP Paribas Easy reached a high of €16.93 (on October 17, 2024) and a low of €13.83 (on April 7, 2025).

What is the market cap and P/E ratio for BLUE?

Curious about BNP Paribas Easy's size and valuation? Its market capitalization stands at 463.10M. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.99, and the forward P/E (looking ahead) is N/A.

Does BLUE pay dividends? If so, what's the yield?

As for dividends, BNP Paribas Easy isn't currently offering a significant yield, or that specific data isn't available right now.

Who are BNP Paribas Easy's main competitors or similar companies to consider before investing?

When looking at BNP Paribas Easy, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Abivax SA ABVX	4.49B	Healthcare	Biotechnology	474.95%	572.59%
Medincell S.A MEDCL	524.62M	Healthcare	Biotechnology	-0.06%	197.92%
Valneva SE VLA	546.93M	Healthcare	Biotechnology	11.58%	-65.68%
Inventiva S.A IVA	391.52M	Healthcare	Biotechnology	32.41%	-46.04%
Nanobiotix NANO	283.01M	Healthcare	Biotechnology	35.01%	44.96%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF? (e.g., ROE, Debt/Equity)

To get a sense of BNP Paribas Easy's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -96.39%, the Debt to Equity ratio from the most recent quarter is 2.22, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for BLUE?

Looking at BNP Paribas Easy's growth, its revenue over the trailing twelve months (TTM) was €26M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of BLUE stock is held by insiders and institutions?

Wondering who owns BNP Paribas Easy stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.